SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-221423
Filing Date
2011-08-12
Accepted
2011-08-12 16:18:51
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 667078
2 CERTIFICATION OF MARC D. BEER, CEO FILED PURSUANT TO SECTION 302 dex311.htm EX-31.1 9970
3 CERTIFICATION OF MARK J. FITZPATRICK, CFO FILED PURSUANT TO SECTION 302 dex312.htm EX-31.2 10005
4 CERTIFICATION OF MARC D. BEER, CEO FILED PURSUANT TO SECTION 906 dex321.htm EX-32.1 4224
5 CERTIFICATION OF MARK J. FITZPATICK, CFO FILED PURSUANT TO SECTION 906 dex322.htm EX-32.2 4257
  Complete submission text file 0001193125-11-221423.txt   2003419

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aegr-20110630.xml EX-101.INS 204533
7 XBRL TAXONOMY EXTENSION SCHEMA aegr-20110630.xsd EX-101.SCH 9439
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20110630_cal.xml EX-101.CAL 33743
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20110630_lab.xml EX-101.LAB 119213
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20110630_pre.xml EX-101.PRE 72783
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 111031642
SIC: 2834 Pharmaceutical Preparations